Current specific immunotherapy for allergic rhinitis: Perspectives from otorhinolaryngologists

Allergy, Asthma and Immunology Research

Volumn 6, Issue 4, 2014, Pages 273-275

  Rhee, Chae Seo ^a,b,c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; HYMENOPTERA VENOM; POLLEN ANTIGEN;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; CHINA; CHRONIC RHINOSINUSITIS; CLINICAL TRIAL (TOPIC); COMORBIDITY; DERMATOPHAGOIDES; DIAGNOSTIC TEST; DISEASE COURSE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EUROPE; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; IMMUNOTHERAPY; MAINTENANCE THERAPY; META ANALYSIS (TOPIC); NOSE POLYP; OTORHINOLARYNGOLOGY; PHYSICIAN ATTITUDE; PRICK TEST; PRIVATE PRACTICE; QUALITY OF LIFE; REIMBURSEMENT; SENSITIZATION; SKIN PRICK TEST; SKIN TEST; SPECIFIC ALLERGEN IMMUNOTHERAPY; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; TREATMENT INDICATION; TREATMENT RESPONSE; UNITED STATES;

EID: 84903436600     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2014.6.4.273     Document Type: Editorial

References (22)

1. Rhee CS, Wee JH, Ahn JC, Lee WH, Tan KL, Ahn S, Lee JH, Lee CH, Cho YS, Park KH, Lee KH, Kim KS, Lee A, Kim JW. Prevalence, risk factors and comorbidities of allergic rhinitis in South Korea: The Fifth Korea National Health and Nutrition Examination Survey. Am J Rhinol Allergy 2014;28:107-14.
2. Zhang Y, Zhang L. Prevalence of allergic rhinitis in China. Allergy Asthma Immunol Res 2014;6:105-13.
3. Noon L. Prophylactic inoculation against hay fever. Int Arch Allergy Appl Immunol 1953;4:285-8.
4. Cohen SG, Evans R 3rd. Allergen immunotherapy in historical perspective. Clin Allergy Immunol 2004;18:1-36.
5. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 2004;59:1205-10.
6. Chang H, Han DH, Mo JH, Kim JW, Kim DY, Lee CH, Min YG, Rhee CS. Early compliance and efficacy of sublingual immunotherapy in patients with allergic rhinitis for house dust mites. Clin Exp Otorhinolaryngol 2009;2:136-40.
7. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol 2010; 126:969-75.
8. Radulovic S, Wilson D, Calderon M, Durham S. Systematic reviews of sublingual immunotherapy (SLIT). Allergy 2011;66:740-52.
9. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001;31:1392-7.
10. Mun SJ, Shin JM, Han DH, Kim JW, Kim DY, Lee CH, Min YG, Rhee CS. Efficacy and safety of a once-daily sublingual immunotherapy without escalation regimen in house dust mite-induced allergic rhinitis. Int Forum Allergy Rhinol 2013;3:177-83.
11. Katelaris CH, Lai CK, Rhee CS, Lee SH, Yun WD, Lim-Varona L, Quang VT, Hwang J, Singh H, Kim J, Boyle JM, Dhong HJ, Narayanan P, Vicente G, Blaiss M, Sacks R. Nasal allergies in the Asian-Pacific population: results from the Allergies in Asia-Pacific Survey. Am J Rhinol Allergy 2011;25 Suppl 1:S3-15.
12. Zhou H, Tao QL, Wei JM, Xu G, Cheng L. Trends in specific immunotherapy for allergic rhinitis: a survey of Chinese ENT specialists. Allergy Asthma Immunol Res. 2014;6:296-303.
13. Cornelis M, Rombaux P, Jorissen M, Hellings PW. Nationwide survey on immunotherapy practice by ENT specialists. Rhinology 2014;52:72-7.
14. Lee JE, Ahn JC, Han DH, Kim DY, Kim JW, Cho SH, Park HW, Rhee CS. Variability of offending allergens of allergic rhinitis according to age: optimization of skin prick test allergens. Allergy Asthma Immunol Res 2014;6:47-54.
15. Bousquet PJ, Hooper R, Kogevinas M, Jarvis D, Burney P. Number of allergens to be tested to assess allergenic sensitization in epidemiologic studies: results of the European Community Respiratory Health Survey I. Clin Exp Allergy 2007;37:780-7.
16. Li J, Sun B, Huang Y, Lin X, Zhao D, Tan G, Wu J, Zhao H, Cao L, Zhong N; China Alliance of Research on Respiratory Allergic Disease. A multicentre study assessing the prevalence of sensitizations in patients with asthma and/or rhinitis in China. Allergy 2009;64: 1083-92.
17. Nelson HS. Multiallergen immunotherapy for allergic rhinitis and asthma. J Allergy Clin Immunol 2009;123:763-9.
18. Amar SM, Harbeck RJ, Sills M, Silveira LJ, O'Brien H, Nelson HS. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract. J Allergy Clin Immunol 2009;124:150-6.e1-5.
19. Lee JE, Choi YS, Kim MS, Han DH, Rhee CS, Lee CH, Kim DY. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis. Ann Allergy Asthma Immunol 2011;107:79-84.
20. Passalacqua G. The use of single versus multiple antigens in specific allergen immunotherapy for allergic rhinitis: review of the evidence. Curr Opin Allergy Clin Immunol 2014;14:20-4.
21. Dhanasekar G, Izzat AB, D'Souza AR. Immunotherapy for allergic rhinitis--a United Kingdom survey and short review. J Laryngol Otol 2005;119:799-805.
22. Ariano R, Berto P, Tracci D, Incorvaia C, Frati F. Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma. Allergy Asthma Proc 2006;27:159-63.